WallStreetZenWallStreetZen

NASDAQ: KTTA
Pasithea Therapeutics Corp Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

KTTA past revenue growth

How has KTTA's revenue growth performed historically?
Company
3,039.7%
Industry
69.21%
Market
13.96%
KTTA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
KTTA's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
KTTA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

KTTA earnings and revenue history

Current Revenue
$472.9k
Current Earnings
-$15.9M
Current Profit Margin
-3,362.2%

KTTA Return on Equity

Current Company
-35.4%
Current Industry
-17.9%
Current Market
34.8%
KTTA's Return on Equity (-35.4%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when KTTA announces earnings.

KTTA Return on Assets

Current Company
-33.5%
Current Industry
1%
KTTA is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

KTTA Return on Capital Employed

Current Company
-39.81%
Current Industry
14.2%

KTTA vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
KTTA$472.90k-$15.63M-$15.90M+3,039.70%N/A
PULM$6.41M-$16.74M-$18.31M+67.37%N/A
TOVX$0.00-$21.55M-$20.23MN/AN/A
PSTV$730.00k-$19.56M-$20.96M-35.32%N/A
CING$0.00-$16.11M-$16.68MN/AN/A
View Top Biotech Stocks

KTTA earnings dates

Next earnings date
May 31, 2023

Pasithea Therapeutics Earnings & Revenue FAQ

What were KTTA's earnings last quarter?

On Invalid Date, Pasithea Therapeutics (NASDAQ: KTTA) reported Q1 2023 earnings per share (EPS) of -$0.14, up 100% year over year. Total Pasithea Therapeutics earnings for the quarter were -$3.54 million. In the same quarter last year, Pasithea Therapeutics's earnings per share (EPS) was -$0.07.

If you're new to stock investing, here's how to buy Pasithea Therapeutics stock.

What was KTTA's earnings growth in the past year?

As of Q2 2023, Pasithea Therapeutics's earnings has grown year over year. Pasithea Therapeutics's earnings in the past year totalled -$15.90 million.

What is KTTA's earnings date?

Pasithea Therapeutics's earnings date is Invalid Date. Add KTTA to your watchlist to be reminded of KTTA's next earnings announcement.

What was KTTA's revenue last quarter?

On Invalid Date, Pasithea Therapeutics (NASDAQ: KTTA) reported Q1 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Pasithea Therapeutics's revenue was $0.00.

What was KTTA's revenue growth in the past year?

As of Q2 2023, Pasithea Therapeutics's revenue has grown 3,039.7% year over year. This is 2,970.48 percentage points higher than the US Biotechnology industry revenue growth rate of 69.21%. Pasithea Therapeutics's revenue in the past year totalled $472.90 thousand.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.